Gergely Keszler, Ph.D. - Publications

Affiliations: 
2004 Semmelweis Egyetem, Hungary 
Area:
Biochemistry, Cell Biology, Oncology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Spasokoukotskaja T, Csapó Z, Virga S, Sasvári-Székely M, Staub M, Keszler G. Effects of intracellular calcium chelation and pifithrin-alpha on deoxynucleotide metabolism in human lymphocytes. Nucleosides, Nucleotides & Nucleic Acids. 25: 1181-4. PMID 17065086 DOI: 10.1080/15257770600894402  0.667
2006 Keszler G, Spasokoukotskaja T, Sasvári-Székely M, Eriksson S, Staub M. Deoxycytidine kinase is reversibly phosphorylated in normal human lymphocytes. Nucleosides, Nucleotides & Nucleic Acids. 25: 1147-51. PMID 17065080 DOI: 10.1080/15257770600894345  0.703
2006 Staub M, Stenger A, Sumeg R, Spasokoukotskaja T, Fairbanks LD, Simmonds HA, Keszler G. The neuroleptic chlorpromazine inhibits the cationic and stimulates the anionic phospholipid precursor synthesis in human lymphocytes. Nucleosides, Nucleotides & Nucleic Acids. 25: 1133-9. PMID 17065078 DOI: 10.1080/15257770600894295  0.617
2005 Demeter A, Sziller I, Csapo Z, Olah J, Keszler G, Jeney A, Papp Z, Staub M. Molecular prognostic markers in recurrent and in non-recurrent epithelial ovarian cancer. Anticancer Research. 25: 2885-9. PMID 16080542  0.54
2005 Keszler G, Virga S, Spasokoukotskaja T, Bauer PI, Sasvari-Szekely M, Staub M. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity. Archives of Biochemistry and Biophysics. 436: 69-77. PMID 15752710 DOI: 10.1016/J.Abb.2005.01.009  0.711
2004 Keszler G, Spasokoukotskaja T, Virga S, Sasvari-Szekely M, Staub M. Stimulation of deoxycytidine kinase results in prolonged maintenance of the enzyme activity. Nucleosides, Nucleotides & Nucleic Acids. 23: 1357-61. PMID 15571258 DOI: 10.1081/Ncn-200027618  0.711
2004 Keszler G, Spasokoukotskaja T, Csapo Z, Virga S, Staub M, Sasvari-Szekely M. Selective increase of dATP pools upon activation of deoxycytidine kinase in lymphocytes: implications in apoptosis. Nucleosides, Nucleotides & Nucleic Acids. 23: 1335-42. PMID 15571254 DOI: 10.1081/Ncn-200027586  0.719
2004 Keszler G, Spasokoukotskaja T, Csapo Z, Talianidis I, Eriksson S, Staub M, Sasvari-Szekely M. Activation of deoxycytidine kinase in lymphocytes is calcium dependent and involves a conformational change detectable by native immunostaining. Biochemical Pharmacology. 67: 947-55. PMID 15104248 DOI: 10.1016/J.Bcp.2003.10.019  0.686
2004 Vegh E, Al-Farhat Y, Spasokoukotskaja T, Keszler G, Nagy T, Staub M, Bodoky G. Gemcitabine treatment enhances the activity of deoxycytidine kinase in periferial lymphocytes of patients with pancreatic cancer Zeitschrift FüR Gastroenterologie. 42. DOI: 10.1055/S-2004-827078  0.67
2003 Csapo Z, Keszler G, Safrany G, Spasokoukotskaja T, Talianidis I, Staub M, Sasvari-Szekely M. Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes. Biochemical Pharmacology. 65: 2031-9. PMID 12787883 DOI: 10.1016/S0006-2952(03)00182-5  0.712
2003 Keszler G, Szikla K, Kazimierczuk Z, Spasokoukotskaja T, Sasvari-Szekely M, Staub M. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes. Biochemical Pharmacology. 65: 563-71. PMID 12566083 DOI: 10.1016/S0006-2952(02)01557-5  0.731
2001 Demeter A, Abonyi M, Look KY, Keszler G, Staub M, Weber G. Differences in thermostability of thymidine kinase isoenzymes in normal ovary and ovarian carcinoma. Anticancer Research. 21: 353-8. PMID 11299761  0.646
2000 Keszler G, Csapó Z, Spasokoutskaja T, Sasvari-Székely M, Virga S, Demeter A, Eriksson S, Staub M. Hyperthermy increase the phosphorylation of deoxycytidine in the membrane phospholipid precursors and decrease its incorporation into DNA. Advances in Experimental Medicine and Biology. 486: 333-7. PMID 11783510 DOI: 10.1007/0-306-46843-3_64  0.666
1999 Spasokoukotskaja T, Sasvári-Székely M, Keszler G, Albertioni F, Eriksson S, Staub M. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity. European Journal of Cancer (Oxford, England : 1990). 35: 1862-7. PMID 10674004 DOI: 10.1016/S0959-8049(99)00223-3  0.699
1998 Csapó Z, Keszler G, Sasvári-Székely M, Smid K, Noordhuis P, Peters GJ, Staub M. Similar changes were induced by Cladribine and by gemcitabine, in the deoxypyrimidine salvage, during short-term treatments. Advances in Experimental Medicine and Biology. 431: 525-9. PMID 9598122 DOI: 10.1007/978-1-4615-5381-6_102  0.686
1997 Staub M, Keszler G, Sasvári-Székely M, Spasokukotskaja T. Modulation of deoxycytidine kinase substrate specificity in lymphocyte Clinical Biochemistry. 30: 283. DOI: 10.1016/S0009-9120(97)87800-9  0.653
1997 Csapó Z, Keszler G, Sasvári-Székely M, Smid K, Noordhuis P, Peters GJ, Staub M. Similar changes were induced by Cladribine and gemcitabine in the deoxypyrimidine salvage, during short term treatments Clinical Biochemistry. 30: 251. DOI: 10.1016/S0009-9120(97)87667-9  0.587
Show low-probability matches.